The Valsartan Antihypertensive Long-Term Use Evaluation trial was a multicentre , double-masked , randomized controlled , parallel group trial comparing the effects of an angiotensin receptor blocker ( valsartan ) and a calcium channel blocker ( amlodipine ) in patients with hypertension and high cardiovascular risk .